Industry Insights
Detecting the Presence of Cancer in Patients’ Breath
Industry InsightThermo Fisher Scientific and Owlstone Medical have recently entered a collaboration, with the aim of advancing breath diagnostics for the early diagnosis of cancer and other diseases. Dr Max Allsworth, Chief Science Officer, Owlstone Medical, and Dominic Roberts, Product Marketing Manager, Orbitrap GC-MS, Thermo Fisher Scientific tell us more about the collaboration and the advantages that breath biopsies can bring to disease detection.
Read More
Using Protein Biomarkers Increases the Chances of Success in Clinical Trials
Industry InsightMany clinical trials fail due to lack of efficacy. But while some of this may be due to poor target selection during the drug discovery process, it’s becoming increasingly clear that only certain patients respond to treatments. So how exactly does precision medicine increase the likelihood of success in clinical trials?
Read More
Simplifying Next-generation Sequencing in the Clinic
Industry InsightWe recently spoke to Luca Quagliata, Ph.D., Global Head of Medical Affairs for Clinical NGS and Oncology at Thermo Fisher Scientific, to discuss some of the barriers preventing full adoption of NGS-based genomic testing in hospitals, and learn more about a solution that can help to address these.
Read More
An Online Educational Resource for Cell Scientists
Industry InsightIntroduced back in March 2019, Cell MentorTM is an online educational resource for biology students and researchers, created by Cell Signaling Technology and Cell Press. To open the resource up to even more scientists, a Chinese version of the site was recently launched.
Read More
Tackling Immune Dysregulation – A Key Driver of Disease
Industry InsightImmune dysregulation plays a central role in many pathologies. We spoke with Dr Fabienne Charrier-Savournin, from Cisbio, to learn more about the mechanisms underpinning immune dysregulation and how this knowledge is applied for therapeutic intervention.
Read More
Mass Spectrometry in the Clinical Lab: The Importance of Choosing a Medical Device
Industry InsightIn this interview, SCIEX’s Francis Fung highlights the benefits that mass spectrometry can bring to clinical laboratories, and discusses why when selecting a mass spectrometer, it is important to consider choosing a medical device.
Read More
Harnessing Gamma T Cells To Bring Effective Therapies to Patients
Industry InsightTechnology Networks recently spoke with Natalie Mount, CEO of Adaptate BioTherapeutics, to learn more about the company's aims and the challenges faced when developing immunotherapies and advancing them into clinical studies.
Read More
Thermo Fisher Scientific Joins the Pistoia Alliance
Industry InsightRecently, Thermo Fisher Scientific announced its membership of the Pistoia Alliance. At the Lab of the Future Congress 2019, we spoke with members of the Thermo Fisher team to learn more about the goals of joining the alliance, and what innovation means to Thermo Fisher.
Read More
Celebrations All Round for Analysis Veterans
Industry InsightAs a stalwart in the biological and chemical analysis fields, JEOL celebrates its 70th anniversary this year. But that’s not all it is celebrating, with the appointment of 35-year veteran of JEOL USA, Bob Pohorenec as President of the company this year.
Read More
How a Female Executive Became a Leader in the Business of Science
Industry InsightTrisha Rice, VP & GM Materials Science Business at Thermo Fisher Scientific, shares her experiences as a woman in science, and provides tips on how to be your most "authentic self" in the field.
Read More
